Over-representation analysis further demonstrated enrichment of cell cycle–related signaling pathways, including the G2/M checkpoint and E2F targets, in the HOXC11-high group (Fig. 7F), supporting its role as a driver of proliferative signaling in ACC. The gene discussed is HOXC11; the disease is adrenal cortex carcinoma.